Confident that you know everything you need to know about your prescription drugs? According to a recent study published in the New England Journal of Medicine, drug companies still aren’t telling consumers the whole story.
Emergency room visits for heart attack sufferers could result in an increased risk of serious bleeding, especially if too much blood thinner is administered.
NeutroSpec, an imaging agent used to diagnose internal infections, has been pulled from the market after being linked to two deaths, 20 severe reactions, and 46 other “less” severe reactions.
After months of alerting doctors about Paxil’s risk to pregnant women, the Food and Drug Administration (FDA) is making it official.
The FDA requested GlaxoSmithKline classify the antidepressant drug as “Category D.” This classification means that studies show that there is an elevated risk to the unborn child in pregnant women. Two studies of expectant mothers taking Paxil during the first trimester indicated their babies were twice as likely to have heart defects.
Check your medicine cabinets--certain eye drops and pain medications made by Molecular Biologics Inc. should be discarded immediately, according to an alert by the Food and Drug Administration (FDA). The federal agency stated that that company hadn’t used proper manufacturing regulations to maintain the sterility of the eye drops and that some of the pain medications didn’t have instructions for safe use.
Merck & Co. will have to start their third Vioxx trial all over again after a U.S. judge declared a mistrial. Next time around though, there will be new allegations to defend. Recent news surfaced that the company withheld information from the New England Journal of Medicine about a 2000 Vioxx study to make the drug appear safer.
Older models of antipsychotic drugs may not carry the same Food and Drug Administration (FDA) warnings as newer models of drugs, but that does not mean they are safer for the elderly. In fact, studies show older versions of antipsychotic drugs are more dangerous for elderly patients than newer drugs that already carry warning labels.
Campath may be approved by the Food and Drug Administration (FDA) to treat leukemia, but that doesn’t mean multiple sclerosis (MS) patients should take the drug.